Influence of body fat distribution on free fatty acid metabolism in obesity

M D Jensen, M W Haymond, R A Rizza, P E Cryer, J M Miles, M D Jensen, M W Haymond, R A Rizza, P E Cryer, J M Miles

Abstract

In order to determine whether differences in body fat distribution result in specific abnormalities of free fatty acid (FFA) metabolism, palmitate turnover, a measure of systemic adipose tissue lipolysis, was measured in 10 women with upper body obesity, 9 women with lower body obesity, and 8 nonobese women under overnight postabsorptive (basal), epinephrine stimulated and insulin suppressed conditions.

Results: Upper body obese women had greater (P less than 0.005) basal palmitate turnover than lower body obese or nonobese women (2.8 +/- 0.2 vs. 2.1 +/- 0.2 vs. 1.8 +/- 0.2 mumol.kg lean body mass (LBM)-1.min-1, respectively), but a reduced (P less than 0.05) net lipolytic response to epinephrine (59 +/- 7 vs. 79 +/- 5 vs. 81 +/- 7 mumol palmitate/kg LBM, respectively). Both types of obesity were associated with impaired suppression of FFA turnover in response to euglycemic hyperinsulinemia compared to nonobese women (P less than 0.005). These specific differences in FFA metabolism may reflect adipocyte heterogeneity, which may in turn affect the metabolic aberrations associated with different types of obesity. These findings emphasize the need to characterize obese subjects before studies.

References

    1. J Clin Invest. 1986 Dec;78(6):1568-78
    1. Ann N Y Acad Sci. 1959 Sep 25;82:420-30
    1. Am J Physiol. 1987 Feb;252(2 Pt 1):E189-96
    1. Am J Physiol. 1987 Mar;252(3 Pt 1):E431-8
    1. Am J Physiol. 1988 May;254(5 Pt 1):E562-5
    1. J Clin Endocrinol Metab. 1965 Oct;25(10):1375-84
    1. Acta Med Scand. 1969 Apr;185(4):351-6
    1. Metabolism. 1969 Oct;18(10):840-51
    1. Diabetologia. 1968 Jan;4(1):20-5
    1. J Clin Invest. 1970 Jun;49(6):1213-23
    1. N Engl J Med. 1970 Mar 19;282(12):668-75
    1. Diabetologia. 1976 Dec;12(6):563-71
    1. Am J Physiol. 1978 Jan;234(1):E84-93
    1. Diabetes. 1978;27 Suppl 1:170-7
    1. Metabolism. 1978 May;27(5):589-97
    1. J Clin Invest. 1979 Jun;63(6):1119-23
    1. Eur J Clin Invest. 1979 Oct;9(5):327-32
    1. Metabolism. 1981 Mar;30(3):274-8
    1. Metabolism. 1981 Sep;30(9):936-40
    1. J Clin Endocrinol Metab. 1982 Feb;54(2):254-60
    1. Metabolism. 1982 Sep;31(9):884-95
    1. Diabetes. 1983 Feb;32(2):117-23
    1. J Lipid Res. 1983 Jan;24(1):96-9
    1. J Clin Invest. 1983 Sep;72(3):1150-62
    1. J Clin Invest. 1983 Nov;72(5):1737-47
    1. Metabolism. 1984 Jan;33(1):68-75
    1. J Clin Endocrinol Metab. 1984 Mar;58(3):544-8
    1. J Clin Invest. 1984 Oct;74(4):1515-25
    1. J Clin Invest. 1985 Apr;75(4):1106-15
    1. J Lab Clin Med. 1985 Dec;106(6):624-9
    1. J Clin Endocrinol Metab. 1986 Aug;63(2):481-4
    1. Mayo Clin Proc. 1988 Sep;63(9):864-8
    1. J Clin Invest. 1963 Jul;42:1054-63
    1. Lancet. 1963 Apr 13;1(7285):785-9
    1. Am J Clin Nutr. 1965 Apr;16:363-9
    1. Proc Soc Exp Biol Med. 1960 May;104:119-20
    1. J Clin Invest. 1987 Jan;79(1):207-13

Source: PubMed

3
Abonnere